Medicare Enrolled
Dr. Aparna Mahakala, M.D.
Endocrinology · Lawrenceville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mahakala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mahakala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mahakala
Dr. Aparna Mahakala is an endocrinology specialist in Lawrenceville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mahakala performed 1,967 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mahakala received a total of $10,474 from 51 pharmaceutical and/or device companies across 616 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mahakala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 30% volume in GA
$10,474 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,967
Medicare services
Top 30% in GA for endocrinology
Not available
Unique patients (not deduplicated)
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
787 | $86 | $240 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
348 | $3 | $14 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
220 | $25 | $150 |
| Diabetes self-management training, individual Individualized education and training for managing diabetes, billed per 30-minute session. |
179 | $39 | $145 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
121 | $59 | $170 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
86 | $74 | $250 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
66 | $6 | $13 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
58 | $116 | $310 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $102 | $375 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
19 | $105 | $500 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
17 | $42 | $110 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
12 | $36 | $270 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,474
Total received (2018-2024)
Avg $1,496/year across 7 years
Top 24% in GA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
616
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,190
2023
$1,778
2022
$1,769
2021
$1,382
2020
$626
2019
$1,513
2018
$1,216
Payments by company (2024)
Novo Nordisk Inc
$333
Abbott Laboratories
$250
Lilly USA, LLC
$214
Tandem Diabetes Care, Inc.
$205
Amgen Inc.
$203
BETA BIONICS, INC.
$143
Bayer Healthcare Pharmaceuticals Inc.
$92
SANOFI-AVENTIS U.S. LLC
$85
Xeris Pharmaceuticals, Inc.
$83
Dexcom, Inc.
$67
ABBVIE INC.
$63
Insulet Corporation
$49
Corcept Therapeutics
$49
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
Verity Pharmaceuticals Inc.
$44
Astellas Pharma US Inc
$42
AstraZeneca Pharmaceuticals LP
$39
Ascensia Diabetes Care Us Inc.
$35
Amneal Pharmaceuticals LLC
$33
RECORDATI_RARE_DISEASES_INC.
$31
CeQur Corporation
$25
Chiesi USA, Inc.
$22
Embecta Corp.
$19
IBSA Pharma Inc.
$17
Top 3 companies account for 36.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,316
Lilly USA, LLC
$987
SANOFI-AVENTIS U.S. LLC
$843
AstraZeneca Pharmaceuticals LP
$782
Insulet Corporation
$584
Abbott Laboratories
$540
Amgen Inc.
$513
Dexcom, Inc.
$435
Tandem Diabetes Care, Inc.
$424
Xeris Pharmaceuticals, Inc.
$308
Boehringer Ingelheim Pharmaceuticals, Inc.
$235
Becton, Dickinson and Company
$227
Corcept Therapeutics
$224
Janssen Pharmaceuticals, Inc
$170
Medtronic MiniMed, Inc.
$170
BETA BIONICS, INC.
$143
Amneal Pharmaceuticals LLC
$122
Horizon Therapeutics plc
$119
CeQur Corporation
$119
Bayer Healthcare Pharmaceuticals Inc.
$92
Radius Health, Inc.
$84
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$83
Amarin Pharma Inc.
$80
ABBVIE INC.
$79
Merck Sharp & Dohme Corporation
$69
IBSA Pharma Inc.
$68
Ascensia Diabetes Care Us Inc.
$51
DEXCOM, INC.
$47
AbbVie Inc.
$47
RECORDATI_RARE_DISEASES_INC.
$47
Verity Pharmaceuticals Inc.
$44
Astellas Pharma US Inc
$42
AbbVie, Inc.
$35
MannKind Corporation
$34
Regeneron Healthcare Solutions, Inc.
$32
Senseonics, Incorporated
$29
Alexion Pharmaceuticals, Inc.
$26
Esperion Therapeutics, Inc.
$23
Chiesi USA, Inc.
$22
PFIZER INC.
$20
Embecta Corp.
$19
Eisai Inc.
$17
Mannkind Corporation
$17
EUSA Pharma (US) LLC
$15
Averitas Pharma Inc.
$15
Roche Diabetes Care, Inc.
$14
Silk Road Medical, Inc.
$14
Kyowa Kirin, Inc.
$14
Amryt Pharma Holdings Ltd
$13
Medtronic, Inc.
$11
Gemini Laboratories, LLC
$11
Top 3 companies account for 39.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Accu-Chek Guide Me · BAQSIMI · BASAGLAR · BD 6cess · BD NANO · BD Nano · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom G6 Transmitter · ENROUTE Transcarotid Stent · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FIASP · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · INVOKANA · ISTURISA · JANUVIA · JARDIANCE · Kerendia · Korlym · LYUMJEV · Lenvima · MOUNJARO · MYCAPSSA · Minimed 670G System · NEXLETOL · Omnipod · Ozempic · PENNSAID · PRALUENT ALIROCUMAB INJECTION · Prolia · QUTENZA · RAYOS · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tymlos · UNITHROID · Vascepa · Veozah · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
72
County median income
$84,823
Nearest hospital to ZIP centroid (approximate)
SUMMITRIDGE CENTER- PSYCHIATRY & ADDICTIVE MED
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mahakala is a clinical cardiology specialist, with above-average Medicare volume (top 30% in GA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mahakala experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mahakala performed 787 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mahakala receive payments from pharmaceutical companies?
Yes. Dr. Mahakala received a total of $10,474 from 51 companies across 616 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mahakala's costs compare to other endocrinologists in Lawrenceville?
Dr. Mahakala's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mahakala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Lawrenceville
Browse endocrinologists in Lawrenceville ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in GA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in GA
Which GA endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology